These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

546 related articles for article (PubMed ID: 2827898)

  • 1. Effects of interferon-gamma on the activation of human T lymphocytes.
    Siegel JP
    Cell Immunol; 1988 Feb; 111(2):461-72. PubMed ID: 2827898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of interferon-gamma and tumour necrosis factor-alpha on the development of cytotoxic T lymphocytes in autologous mixed lymphocyte tumour cultures with human melanoma.
    Roth AD; Hornicek FJ; Gerstner CG; Kirkwood JM
    Clin Exp Immunol; 1991 Oct; 86(1):163-72. PubMed ID: 1833098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of HLA antigens on renal tubular cells in culture. II. Effect of increased HLA antigen expression on tubular cell stimulation of lymphocyte activation and on their vulnerability to cell-mediated lysis.
    Bishop GA; Waugh JA; Hall BM
    Transplantation; 1988 Aug; 46(2):303-10. PubMed ID: 2970135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergistic effects of IL-7 and IL-12 on human T cell activation.
    Mehrotra PT; Grant AJ; Siegel JP
    J Immunol; 1995 May; 154(10):5093-102. PubMed ID: 7730615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential effects of human alpha and gamma interferon on mixed lymphocyte culture and on T-cell-mediated cytotoxicity. Inhibition of proliferation but not of IL-2 production by alpha interferons.
    Chae F; Oleszak E; Fox FE; Trotta P; Mele CA; Hawrylko E; Platsoucas CD
    Int Arch Allergy Appl Immunol; 1988; 86(4):361-9. PubMed ID: 2970436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improvement of decreased interleukin 2 (IL-2) responsiveness and IL-2 production in autologous mixed-lymphocyte reaction of cord blood lymphocytes by interferon-gamma and IL-2 and the role of HLA-DQ antigen.
    Kawano Y; Noma T; Yata J
    Cell Immunol; 1987 Nov; 110(1):56-67. PubMed ID: 2960462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The different effect of alpha and gamma interferons and interleukin 2 on the expression of CD2, CD3, CD4 and CD8 antigens in comparison to histocompatibility antigens of human lymphocytes.
    Kotlán B; Böck G; Rajnavölgyi E; Benczur M; Mátyus L; Gyódi E; Huber C; Petrányi GG
    Immunol Lett; 1988 Aug; 18(4):259-68. PubMed ID: 2460402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Type I IFN-mediated enhancement of anti-leukemic cytotoxicity of gammadelta T cells expanded from peripheral blood cells by stimulation with zoledronate.
    Watanabe N; Narita M; Yokoyama A; Sekiguchi A; Saito A; Tochiki N; Furukawa T; Toba K; Aizawa Y; Takahashi M
    Cytotherapy; 2006; 8(2):118-29. PubMed ID: 16698685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interferon-gamma regulates the T cell response to precursor nevi and biologically early melanoma.
    Guerry D; Alexander MA; Elder DE; Herlyn MF
    J Immunol; 1987 Jul; 139(1):305-12. PubMed ID: 3108402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of the human immature natural killer cell subset by IL-12 and its regulation by endogenous TNF-alpha and IFN-gamma secretion.
    Jewett A; Bonavida B
    Cell Immunol; 1994 Apr; 154(1):273-86. PubMed ID: 7907529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD69, CD25, and HLA-DR activation antigen expression on CD3+ lymphocytes and relationship to serum TNF-alpha, IFN-gamma, and sIL-2R levels in aging.
    Rea IM; McNerlan SE; Alexander HD
    Exp Gerontol; 1999 Jan; 34(1):79-93. PubMed ID: 10197730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The control of class II expression on T cells is independent of the regulation of Tac and the induction of proliferation.
    Salvadori S; Pizzimenti A; Cohen S; Zier KS
    Clin Exp Immunol; 1991 Dec; 86(3):544-9. PubMed ID: 1836164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression of the allogeneic response by human IL-10: a critical role for suppression of a synergy between IL-2 and TNF-alpha.
    Tadmori W; Zhang M; Beavis AJ; Sullivan LM; Narula SK
    Cytokine; 1994 Sep; 6(5):462-71. PubMed ID: 7827283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Interleukin-12 restores and promotes the T-cell immune function inhibited by 5-fluorouracil].
    Chi PD; Li L; Fan YY; Wu CY
    Ai Zheng; 2007 Aug; 26(8):801-8. PubMed ID: 17697537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin-2 stimulates resting human T lymphocytes' response to allogeneic, gamma interferon-treated keratinocytes.
    Morhenn VB; Nickoloff BJ
    J Invest Dermatol; 1987 Nov; 89(5):464-8. PubMed ID: 3117903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin 2 receptor blockade by anti-Tac antibody inhibits IFN-gamma induction.
    Croll AD; Wilkinson MF; Morris AG
    Cell Immunol; 1985 Apr; 92(1):184-9. PubMed ID: 3000625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ability of pure resting CD8+ human T cells to respond to alloantigen.
    Leivestad T; Halvorsen R; Gaudernack G; Thorsby E
    Scand J Immunol; 1989 May; 29(5):543-53. PubMed ID: 2524873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human CD4+ T cells proliferate to HLA-DR+ allogeneic vascular endothelium. Identification of accessory interactions.
    Savage CO; Hughes CC; McIntyre BW; Picard JK; Pober JS
    Transplantation; 1993 Jul; 56(1):128-34. PubMed ID: 7687392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of CD8+ effector T cells is differentially regulated by IL-18 and IL-12.
    Okamoto I; Kohno K; Tanimoto T; Ikegami H; Kurimoto M
    J Immunol; 1999 Mar; 162(6):3202-11. PubMed ID: 10092771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro cell-mediated immune responses to Plasmodium falciparum schizont antigens in adults from a malaria endemic area: CD8+ T lymphocytes inhibit the response of low responder individuals.
    Mshana RN; McLean S; Boulandi J
    Int Immunol; 1990; 2(12):1121-32. PubMed ID: 2151024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.